T6Z-81799-22422
2 vaccinations
1 coded response
1 check-in
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 913 / CA
- Registered
- 2021-08-26
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-08-05
Dose 1 — Pfizer-BioNTech
-
2021-08-25
Dose 2 — Pfizer-BioNTech
-
2021-08-26
Registered in v-safe
-
2021-08-26
Survey response — days 1–6 daily, dose 2MedDRA: Injection site pain — Feeling: Good · Site: Pain · HeadacheFree text: Sore arm where shot was administeredMedDRA releases: 2021-09,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-05 | Pfizer-BioNTech | No |
| 2 | 2021-08-25 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Sore arm where shot was administered
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Injection site pain | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release